Info@ThinkPinkRocks.com

Trovagene to sell underwritten public offering of common stock

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it is offering to sell shares of its common stock in an underwritten public offering. The offering is expected to price on or about Friday, February 6, 2015.

More:
Trovagene to sell underwritten public offering of common stock

Share

Leave a Reply

Solve : *
22 + 19 =